Cargando…
Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction
Monoamine-based treatments for depression have evolved greatly over the past several years, but shortcomings such as suboptimal efficacy, treatment lag, and residual cognitive dysfunction are still significant. Preclinical and clinical studies using compounds directly targeting glutamatergic neurotr...
Autores principales: | Pehrson, Alan L., Sanchez, Connie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968911/ https://www.ncbi.nlm.nih.gov/pubmed/23903233 http://dx.doi.org/10.1017/S1092852913000540 |
Ejemplares similares
-
Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants
por: Pehrson, Alan L, et al.
Publicado: (2015) -
Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
por: Vecera, Courtney M., et al.
Publicado: (2023) -
Vortioxetine Treatment Reverses Subchronic PCP Treatment-Induced Cognitive Impairments: A Potential Role for Serotonin Receptor-Mediated Regulation of GABA Neurotransmission
por: Pehrson, Alan L., et al.
Publicado: (2018) -
Glutamate at the Vertebrate Neuromuscular Junction: From Modulation to Neurotransmission
por: Colombo, Maria Nicol, et al.
Publicado: (2019) -
The Importance of α-Klotho in Depression and Cognitive Impairment and Its Connection to Glutamate Neurotransmission—An Up-to-Date Review
por: Pańczyszyn-Trzewik, Patrycja, et al.
Publicado: (2023)